| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 93.155 | 81.322 | 78.277 | 133.477 | 170.118 | 177.904 | 202.131 | 146.475 | 154.551 | 138.382 |
| Total Income - EUR | 93.459 | 81.430 | 81.148 | 133.643 | 170.285 | 183.314 | 202.268 | 146.541 | 156.613 | 138.386 |
| Total Expenses - EUR | 49.261 | 46.939 | 36.806 | 56.838 | 60.504 | 63.834 | 98.246 | 59.011 | 48.974 | 43.900 |
| Gross Profit/Loss - EUR | 44.198 | 34.491 | 44.342 | 76.805 | 109.780 | 119.480 | 104.022 | 87.530 | 107.639 | 94.485 |
| Net Profit/Loss - EUR | 36.366 | 33.677 | 41.893 | 75.469 | 108.078 | 117.786 | 101.999 | 86.064 | 106.073 | 90.334 |
| Employees | 7 | 7 | 6 | 7 | 7 | 6 | 8 | 6 | 4 | 3 |
Check the financial reports for the company - Tomamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 7.539 | 3.444 | 1.955 | 19.014 | 14.424 | 10.009 | 41.094 | 28.814 | 18.810 | 10.342 |
| Current Assets | 41.566 | 53.103 | 25.578 | 35.069 | 44.832 | 80.846 | 40.799 | 106.309 | 104.916 | 92.549 |
| Inventories | 104 | 1.817 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 9.033 | 8.563 | 10.487 | 18.843 | 25.079 | 30.192 | 18.273 | 98.023 | 94.772 | 80.485 |
| Cash | 32.429 | 42.722 | 15.091 | 16.226 | 19.753 | 50.653 | 22.527 | 8.286 | 10.144 | 12.064 |
| Shareholders Funds | 25.881 | -559 | 53 | 52 | 51 | 50 | 19.166 | 86.113 | 101.181 | 91.159 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 23.224 | 57.105 | 27.480 | 54.031 | 59.205 | 90.805 | 62.727 | 49.010 | 22.545 | 11.731 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Tomamed Srl